Loading...

Chugai Pharmaceutical Co., Ltd.

CHGCY•PNK
Healthcare
Drug Manufacturers - General
$23.19
$-4.03(-14.81%)
U.S. Market opens in NaNh NaNm

Chugai Pharmaceutical Co., Ltd. (CHGCY) Stock Overview

Explore Chugai Pharmaceutical Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap76.5B
P/E Ratio25.65
EPS (TTM)$0.83
ROE0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$28.19
3 Months$26.85
1 Year Target$32.14

CHGCY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Chugai Pharmaceutical Co., Ltd. (CHGCY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 30.61, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $32.14.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 25.65 and a market capitalization of 76.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-14.81%
5-Day Change
-15.49%
1-Month Change
-10.91%
3-Month Change
-17.53%
6-Month Change
4.60%
Year-to-Date (YTD) Change
-11.72%
1-Year Change
-17.74%
3-Year Change
83.76%
5-Year Change
20.09%
All-Time (Max) Change
660.33%

Contact Information

https://www.chugai-pharm.co.jp
81 3 3281 6611
Nihonbashi Mitsui Tower, Tokyo, NaN, 103-8324

Company Facts

5,026 Employees
IPO DateAug 3, 2012
CountryJP
Actively Trading

Frequently Asked Questions